NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q1 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $275 | -100.0% | 2,695 | -78.5% | 0.16% | -80.2% |
| Q3 2020 | $1,092,000 | -1.4% | 12,558 | -0.9% | 0.79% | -0.1% |
| Q2 2020 | $1,107,000 | +15.6% | 12,670 | +9.0% | 0.79% | -3.2% |
| Q1 2020 | $958,000 | +278.7% | 11,620 | +341.8% | 0.82% | +378.4% |
| Q1 2019 | $253,000 | +8.1% | 2,630 | -3.7% | 0.17% | -7.1% |
| Q4 2018 | $234,000 | -2.5% | 2,730 | -1.8% | 0.18% | +17.9% |
| Q3 2018 | $240,000 | +14.3% | 2,780 | 0.0% | 0.16% | +12.2% |
| Q2 2018 | $210,000 | -17.6% | 2,780 | -11.9% | 0.14% | -18.7% |
| Q1 2018 | $255,000 | -12.1% | 3,155 | -8.7% | 0.17% | -17.8% |
| Q4 2017 | $290,000 | -57.5% | 3,455 | -56.5% | 0.21% | -58.4% |
| Q3 2017 | $683,000 | -46.3% | 7,950 | -47.9% | 0.50% | -46.9% |
| Q2 2017 | $1,273,000 | +8.2% | 15,250 | -3.8% | 0.94% | +4.1% |
| Q1 2017 | $1,177,000 | +57.1% | 15,850 | +54.2% | 0.90% | +53.9% |
| Q4 2016 | $749,000 | -2.2% | 10,280 | +5.9% | 0.59% | -8.4% |
| Q3 2016 | $766,000 | +1.7% | 9,704 | +6.3% | 0.64% | -0.9% |
| Q2 2016 | $753,000 | – | 9,129 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |